CES HK Biotechnology Index (CES HK Biotech) is a price return index provides a measure of market performance for biotechnology companies listed on the Stock Exchange of Hong Kong Limited (SEHK).
| Product Name | Product Type |
|---|
| Index Name | No. of Constituents |
|---|---|
| CSI 300 | 300 |
| CSI 500 | 500 |
| SSE 50 | 50 |
| SSE Dividend | 50 |
As of:2021-04-20
| Close | Change(%) | Turnover (100 Million Yuan) | 1 Mo Returns(%) |
|---|---|---|---|
| 12959.64 | 1.47 | 47.01 |
As of:2021-04-20
| Code | Name | Sector | Weight(%) |
|---|---|---|---|
| 1801 | Innovent Biologics, Inc. | Health Care | 10.87 |
| 9926 | Akeso, Inc. | Health Care | 10.66 |
| 2269 | WUXI BIOLOGICS (CAYMAN) INC. | Health Care | 10.30 |
| 2359 | WUXI APPTEC CO., LTD. | Health Care | 10.00 |
| 1177 | Sino Biopharm | Health Care | 9.01 |
| 6185 | CanSino Biologics Inc. | Health Care | 6.04 |
| 2500 | Venus Medtech (Hangzhou) Inc. | Health Care | 5.41 |
| 3759 | Pharmaron Beijing Co., Ltd. | Health Care | 5.05 |
| 9969 | InnoCare Pharma Limited | Health Care | 4.24 |
| 1548 | Genscript Biotech Corporation | Health Care | 3.94 |
沪公网安备 31011502008255号
CSI Indices
CSI Valuation
CSI Ratings
